Bioxcel Therapeutics, Inc.

CT · United States · Reporting entity ID 100001326931

Total reported 2019–2025

$15.0M

#391 of 2,960 reporting companies — 0% of all reported industry payments

$1.18M in general payments across 5,287 records, plus $13.8M in research funding across 369 records.

How it breaks down

General payments $1,177,251

Research funding $13,825,114

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.